Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

220.04 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 81
Open 220.04
Bid (Size) 218.50 (100)
Ask (Size) 222.00 (200)
Prev. Close 220.04
Today's Range 220.04 - 220.04
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 2.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI, JPMorgan Earnings: Why MSFT, NVDA, ABBV, ABAT Are Also On Traders' Radar Today ↗
Retail sentiment remained mixed on Stocktwits, with a neutral view on SPY but growing bullishness around QQQ. 
Via Stocktwits
Topics Artificial Intelligence Credit Cards ETFs
News headline image
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B ↗
When asked about the company’s strategic transactions, CEO Mark Goldsmith said at a conference that the company has a policy of not commenting on rumors or speculation. 
Via Stocktwits

Performance

YTD
-4.0%
-4.0%
1 Month
-3.3%
-3.3%
3 Month
-4.5%
-4.5%
6 Month
+14.9%
+14.9%
1 Year
+24.5%
+24.5%

More News

Read More
News headline image
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
3 No-Brainer Dividend Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
This ETF Is Proof That the Healthcare Rebound Is Real ↗
Via MarketBeat
Topics ETFs
News headline image
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
Via MarketMinute
News headline image
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio ↗
Via The Motley Fool
Topics Economy Intellectual Property Lawsuit
News headline image
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
Via MarketMinute
Topics Intellectual Property
News headline image
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
Via MarketMinute
Topics Intellectual Property
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 We Question
Via StockStory
News headline image
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating ↗
Via MarketBeat
News headline image
Revolution Medicines Stock Soars On Report Of AbbVie Takeover ↗
Via Stocktwits
News headline image
Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
3 Healthcare Stocks with Exciting Potential
Via StockStory
Topics Stocks
Top S&P500 movers in Monday's session ↗
Via Chartmill
News headline image
Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗
Via MarketBeat
Topics Artificial Intelligence Death
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
26 Top Dividend Stocks to Buy and Hold in 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment ↗
Via Stocktwits
News headline image
Take Warren Buffett's Advice: Don't Buy Any Stock in 2026 Unless It Passes This Test ↗
Via The Motley Fool
News headline image
Buying This Healthcare Stock Could Make You a Millionaire Retiree ↗
Via The Motley Fool
Topics Intellectual Property Retirement
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
Via MarketMinute
Topics Economy Intellectual Property Law Enforcement
News headline image
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
AbbVie (ABBV): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
Topics Stocks Supply Chain

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 220.04
When was AbbVie last traded?
The last trade of AbbVie was at 01/12/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.